Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Jinxin Xinan Women and Children Hospital is a prominent private specialty healthcare provider based in Chengdu, China, specializing in assisted reproductive technology (ART). As a flagship facility of the Jinxin Fertility Group, the hospital offers a comprehensive suite of services including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and pre-implantation genetic testing. The institution is recognized as one of the largest private ART providers in Western China, maintaining advanced embryology laboratories and high clinical success rates. Beyond fertility services, the hospital provides integrated care in obstetrics, gynecology, and pediatrics to support patients throughout the entire reproductive cycle. It combines clinical excellence with ongoing research in reproductive medicine to address complex cases of infertility.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Jinxin Xinan Women and Children Hospital.